Both in Pharmaceuticals
Pulmatrix vs Skye Bioscience
Over the past year PULM returned −71.3% and SKYE returned −89.3%; their daily moves had a correlation of 0.00.
PULM −71.3% SKYE −89.3%Growth of $1, one year, split-adjusted
| Metric | PULM | SKYE |
|---|---|---|
| Price | $1.40 | $1.28 |
| Market cap | $5.1M | $5.7M |
| Today | −1.06% | −2.29% |
| 1 month | −9.1% | −20.0% |
| 6 months | +8.5% | −80.6% |
| Year to date | −37.2% | −78.7% |
| 1 year | — | −89.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $2.2M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 63.9% | 616.8% |
| Short % of float | 1.2% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).